ABUS
Arbutus Biopharma Corp · Healthcare · Biotechnology
Señales de momentum (gestores comparables): amplitud de titulares 0.0% · flujo de acciones +3.6% · nuevas posiciones netas 0.0% · fórmula
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q3 2025
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q2 2026 | 74 | +3 | 78.81M | $378.23M | +13 | −11 |
| Q1 2026 | 75 | -5 | 80.64M | $362.88M | +5 | −10 |
| Q4 2025 | 79 | -1 | 77.73M | $373.87M | n/a | −1 |
| Q3 2025 | 16 | 0 | 63.04M | $286.21M | +1 | −1 |
| Q2 2025 | 13 | +1 | 34.03M | $105.14M | +1 | n/a |
| Q1 2025 | 9 | 0 | 10.62M | $37.08M | n/a | n/a |
| Q4 2024 | 9 | 0 | 11.43M | $37.37M | n/a | n/a |
| Q3 2024 | 8 | +1 | 7.82M | $30.10M | +1 | n/a |
| Q2 2024 | 7 | n/a | 7.20M | $22.26M | n/a | n/a |
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Morgan Stanley ✦ | 24.45M | n/a | $111.01M | 0.0% | n/c | 1 | SEC ↗ ×7 |
| 2 | BlackRock ✦ (pasivo) | 12.68M | -1.5% | $57.56M | 0.0% | ▼ Trim | 2 | SEC ↗ ×10 |
| 3 | The Vanguard Group ✦ (pasivo) | 8.99M | -1.0% | $40.82M | 0.0% | ▼ Trim | 2 | SEC ↗ ×5 |
| 4 | Adage Capital Partners ✦ | 5.01M | +94.7% | $22.77M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 5 | State Street Global Advisors ✦ (pasivo) | 4.10M | -8.1% | $18.61M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 6 | Geode Capital Management ✦ (pasivo) | 3.67M | +0.8% | $16.65M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 7 | Goldman Sachs Group ✦ | 2.17M | n/a | $9.87M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 8 | Millennium Management ✦ | 528.34K | +5.8% | $2.40M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 9 | Wellington Management ✦ | 514.08K | -3.3% | $2.33M | 0.0% | ▼ Trim | 6 | SEC ↗ ×3 |
| 10 | JPMorgan Chase ✦ | 196.46K | n/a | $891,918 | 0.0% | n/c | 1 | SEC ↗ ×10 |
| 11 | Citadel Advisors ✦ | 193.69K | +61.0% | $879,357 | 0.0% | ▲ Add | 6 | SEC ↗ |
| 12 | D. E. Shaw & Co. ✦ | 189.95K | +366.7% | $862,382 | 0.0% | ▲ Add | 2 | SEC ↗ ×2 |
| 13 | Arrowstreet Capital ✦ | 159.12K | Nuevo | $722,396 | 0.0% | New | 1 | SEC ↗ |
| 14 | Fidelity (FMR) ✦ | 89.46K | +10.8% | $406,165 | 0.0% | ▲ Add | 2 | SEC ↗ ×2 |
| 15 | T. Rowe Price ✦ | 83.01K | +8.5% | $377,000 | 0.0% | ▲ Add | 6 | SEC ↗ |
| 16 | AQR Capital Management ✦ | 15.23K | -59.6% | $69,158 | 0.0% | ▼ Trim | 5 | SEC ↗ ×5 |
"Their weight" = la participación de la posición en el valor de renta variable 13F reportado por ese manager: la medida de convicción. ✦ = manager curado.
Nuevos compradores
| Arrowstreet Capital | $722,396 | 0.0% |
Posición cerrada
| Two Sigma Investments | $34,914 | era 0.0% |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 166 tenedores, 138.84M acciones, $623.91M declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Qué más suelen tener los titulares rastreados de este valor: recuentos de titularidad compartida, no relaciones fundamentales.
19.5% de clase · Ver presentación original ante la SEC ↗